Patents by Inventor Thomas E. Cross, Jr.
Thomas E. Cross, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11154709Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: April 8, 2019Date of Patent: October 26, 2021Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Publication number: 20190232058Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: ApplicationFiled: April 8, 2019Publication date: August 1, 2019Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, JR., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Patent number: 10300273Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: March 28, 2016Date of Patent: May 28, 2019Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Publication number: 20160279411Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: ApplicationFiled: March 28, 2016Publication date: September 29, 2016Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, JR., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Patent number: 9393416Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: December 30, 2013Date of Patent: July 19, 2016Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Gary W. King, Carl D. Wahlstrand, Kenneth T. Heruth, Thomas E. Cross, Jr., Paul W. Wacnik, Richard T. Stone
-
Patent number: 9320847Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: April 24, 2015Date of Patent: April 26, 2016Assignee: MEDTRONIC, INC.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Patent number: 9302101Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.Type: GrantFiled: March 17, 2014Date of Patent: April 5, 2016Assignee: MEDTRONIC, INC.Inventors: Carl D. Wahlstrand, Gregory A. Hrdlicka, Thomas E. Cross, Jr., Thomas Barry Hoegh, James M. Olsen, Stephen L. Bolea
-
Publication number: 20150224251Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: ApplicationFiled: April 24, 2015Publication date: August 13, 2015Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, JR., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Patent number: 9084872Abstract: The disclosure describes an introducer for facilitating implantation of therapy elements into a patient. The introducer has an elongated body that defines a lumen for advancement of a therapy element to an implant site, and includes a curved portion medially located between substantially straight proximal and distal portions. As an example, the shape of the introducer may allow a clinician to more easily, and without substantially damaging surrounding tissue, find the correct tissue depth and follow that tissue depth to the implant site. For example, the introducer may facilitate implantation of a therapy element within or between desired layers of tissue of the patient. In some embodiments, fluid may be injected through the introducer to create a space within the tissue to implant the therapy element. Fluid may also be evacuated through the introducer prior to implantation.Type: GrantFiled: August 27, 2010Date of Patent: July 21, 2015Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Gary W. King, Thomas E. Cross, Jr., Richard T. Stone
-
Patent number: 9020599Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: December 17, 2013Date of Patent: April 28, 2015Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Publication number: 20140200643Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.Type: ApplicationFiled: March 17, 2014Publication date: July 17, 2014Applicant: Medtronic, Inc.Inventors: Carl D. Wahlstrand, Gregory A. Hrdlicka, Thomas E. Cross, Jr., Thomas Barry Hoegh, James M. Olsen, Stephen L. Bolea
-
Patent number: 8751017Abstract: An electrode assembly is described, which allows close and robust contact with a biological structure such as a nerve while simultaneously preventing compressive injury to the biological structure. The electrode assembly includes a compliant cuff body and at least one reinforcing element in an aspect. The reinforced compliant cuff body may expand and contract to accommodate swelling of underlying biological structures, to accommodate movements of the biological structures associated with body movements, and to closely fit biological structures with irregular or non-uniform cross-sectional profiles. The electrode assembly further includes at least one electrode for sending and/or receiving electric impulse data to/from the biological structure such as a nerve.Type: GrantFiled: November 20, 2012Date of Patent: June 10, 2014Assignee: Neurostream Technologies G.P.Inventors: Willard Wilson, Thomas E. Cross, Jr.
-
Publication number: 20140114374Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: ApplicationFiled: December 30, 2013Publication date: April 24, 2014Applicant: Medtronic, Inc.Inventors: Ethan A. Rooney, Gary W. King, Carl D. Wahlstrand, Kenneth T. Heruth, Thomas E. Cross, JR., Paul W. Wacnik, Richard T. Stone
-
Publication number: 20140107747Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: ApplicationFiled: December 17, 2013Publication date: April 17, 2014Applicant: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
-
Patent number: 8676340Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.Type: GrantFiled: November 24, 2010Date of Patent: March 18, 2014Assignee: Medtronic, Inc.Inventors: Carl D. Wahlstrand, Gregory A. Hrdlicka, Thomas E. Cross, Jr., Thomas Barry Hoegh, James M. Olsen, Stephen L. Bolea
-
Patent number: 8644941Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: June 9, 2006Date of Patent: February 4, 2014Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Jeffrey S. Evanson, Kenneth T. Heruth, Paul W. Wacnik
-
Patent number: 8620435Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.Type: GrantFiled: June 9, 2006Date of Patent: December 31, 2013Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Jeffrey S. Evanson, Kenneth T. Heruth, Paul W. Wacnik
-
Patent number: 8588914Abstract: An implantable medical device (IMD) with a housing and electrodes on at least two surfaces of the housing is described. The surfaces may be, for example, opposed, substantially parallel surfaces, e.g., top and bottom surfaces. Location of electrodes on multiple surfaces of the housing may allow the IMD to deliver stimulation to a variety of tissues and with a variety of current field configurations. For example, the IMD may deliver peripheral nerve field stimulation (PNFS) to one or more tissue areas via electrodes selected from one or both of the surfaces to, for example, reduce the sensation of pain in a tissue area proximate to an implantation site of the IMD without targeting a specific nerve. The IMD may be implanted between or within intra-dermal, deep dermal, or subcutaneous layers of the tissue of the patient to deliver PNFS to any one or more of these layers.Type: GrantFiled: June 9, 2006Date of Patent: November 19, 2013Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Richard T. Stone
-
Publication number: 20130060313Abstract: The present invention provides for an improved apparatus and method for electrical stimulation. A paddle having a thickness up to 0.030 inches is implanted adjacent the spinal cord dura mater to reduce the likelihood of paralysis due to stress on the spinal cord attributed to bulkier leads. The paddle is then positioned so that at least one of a plurality of electrodes is positioned over the area of the spinal cord requiring pain treatment; and then electric stimulation is applied to the electrodes to effect pain treatment. In another embodiment the paddle is curved about a vertical axis to substantially match the shape of a human spinal cord dura mater to help reduce lead migration.Type: ApplicationFiled: December 23, 2011Publication date: March 7, 2013Applicant: MEDTRONIC, INC.Inventor: Thomas E. Cross, JR.
-
Patent number: 8204607Abstract: The disclosure describes an implantable medical lead for delivering stimulation to a patient. Electrodes may be located on two or more surfaces of the lead to, for example, selectively deliver stimulation to one or more tissue layers within the patient. The lead may be implanted within or between intra-dermal, deep dermal, or subcutaneous tissue layers, and may be used to, for example, deliver peripheral nerve field stimulation to treat pain experienced by the patient at the site at which the lead is implanted. The lead may comprise a paddle lead or a multiple level lead, e.g., a lead having a plurality of flat or paddle shaped lead bodies arranged in substantially parallel planes. Further, the lead may include fixation structures on the distal end, proximal end, or both ends to prevent migration.Type: GrantFiled: June 9, 2006Date of Patent: June 19, 2012Assignee: Medtronic, Inc.Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Richard T. Stone